Zobrazeno 1 - 10
of 799
pro vyhledávání: '"Alan S. Maisel"'
Autor:
W. Frank Peacock, Alan S. Maisel, Christian Mueller, Stefan D. Anker, Fred S. Apple, Robert H. Christenson, Paul Collinson, Lori B. Daniels, Deborah B. Diercks, Salvatore Di Somma, Gerasimos Filippatos, Gary Headden, Brian Hiestand, Judd E. Hollander, Juan C. Kaski, Joshua M. Kosowsky, John T. Nagurney, Richard M. Nowak, Donald Schreiber, Gary M. Vilke, Marvin A. Wayne, Martin Than
Publikováno v:
Clinical and Experimental Emergency Medicine, Vol 9, Iss 2, Pp 140-145 (2022)
Objective To determine the utility of a highly sensitive troponin assay when utilized in the emergency department. Methods The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6
Externí odkaz:
https://doaj.org/article/67e33dc205eb4cdeb535b33219cfecf5
Autor:
Irene Müller, Thomas Vogl, Uwe Kühl, Alexander Krannich, Aron Banks, Tobias Trippel, Michel Noutsias, Alan S. Maisel, Sophie vanLinthout, Carsten Tschöpe
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1442-1451 (2020)
Abstract Aims The alarmin S100A8/S100A9 (S100A8/A9) is released by activated monocytes/macrophages and neutrophils in the setting lymphocytic myocarditis (MC). We recently demonstrated its therapeutic potential in experimental acute MC. Now, we inves
Externí odkaz:
https://doaj.org/article/ede98efa1d364ea89de38dd1f70a858a
Autor:
Rebabonye B. Pharithi, Maria Ferre‐Vallverdu, Alan S. Maisel, Eoin O'Connell, Myra Walshe, Claire Sweeney, James Barton, Kathrine McDonald, Daniel O'Hare, Chris Watson, Joe Gallagher, Mark Ledwidge, Kenneth McDonald
Publikováno v:
ESC Heart Failure, Vol 7, Iss 1, Pp 159-167 (2020)
Abstract Aims In the PARADIGM‐heart failure trial, sacubitril‐valsartan demonstrated a reduction in heart failure admissions and reduced all‐cause mortality in patients with heart failure with reduced ejection fraction. Although real world data
Externí odkaz:
https://doaj.org/article/7380faf93da2419aaa0f16bf7514d566
Autor:
Rajiv Vasudevan, Ji H. Shin, Jessica Chopyk, PhD, William F. Peacock, MD, Francesca J. Torriani, MD, Alan S. Maisel, MD, David T. Pride, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 1, Pp 21-30 (2020)
Objective: To determine whether a single-use stethoscope diaphragm barrier surface remains aseptic when placed on pathogen-contaminated stethoscopes. Methods: From May 31 to August 5, 2019, we tested 2 separate barriers using 3 different strains of 7
Externí odkaz:
https://doaj.org/article/53408e92415a46e09c7427fae58873e1
Autor:
Angelo Michele di Candia, Diane Xavier de Avila, Gustavo Rodolfo Moreira, Humberto Villacorta, Alan S. Maisel
Publikováno v:
American Heart Journal Plus, Vol 9, Iss , Pp 100046- (2021)
Growth differentiation factor-15 (GDF-15) is a cytokine upregulated in multiple pathological conditions where oxidative stress, endothelial dysfunction, tissue aging, and chronic inflammation are the hallmarks. GDF-15 has many sources of production,
Externí odkaz:
https://doaj.org/article/c9d19560082c486981d868aee205b681
Autor:
Kim Schwab, Dacloc Nguyen, GilAnthony Ungab, Gregory Feld, Alan S. Maisel, Martin Than, Laura Joyce, W. Frank Peacock
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 2, Iss 4, Pp n/a-n/a (2021)
Abstract Objective Advanced machine learning technology provides an opportunity to improve clinical electrocardiogram (ECG) interpretation, allowing non‐cardiology clinicians to initiate care for atrial fibrillation (AF). The Lucia Atrial Fibrillat
Externí odkaz:
https://doaj.org/article/790ab66636b44a61b9878a9b41800d2d
Publikováno v:
American Heart Journal Plus, Vol 7, Iss , Pp 100039- (2021)
The stethoscope is a tool cherished by the field of cardiology and ubiquitous throughout medicine. However, little consideration has been given to its safe usage regarding its potential for pathogenic contamination despite thorough evidence that stet
Externí odkaz:
https://doaj.org/article/ae5455f07f7a4cfd80d5ffa4894fdff8
Publikováno v:
Indian Heart Journal, Vol 70, Iss 6, Pp 822-827 (2018)
Background: Soluble suppression of tumorigenicity-2 (sST2) is a novel biomarker shown to be useful for prognostic assessment in heart failure (HF). However, very limited data exists about its prognostic utility in patients with HF in India. Methods:
Externí odkaz:
https://doaj.org/article/ff740a15e23841078058f2c3195025cc
Autor:
I. Satyamurthy, Jamshed J. Dalal, J.P.S. Sawhney, J.C. Mohan, Shubha A. Chogle, Nagaraj Desai, Shireesh P. Sathe, Alan S. Maisel
Publikováno v:
Indian Heart Journal, Vol 66, Iss 1, Pp 73-82 (2014)
Despite recent advances, the diagnosis and management of heart failure evades the clinicians. The etiology of congestive heart failure (CHF) in the Indian scenario comprises of coronary artery disease, diabetes mellitus and hypertension. With better
Externí odkaz:
https://doaj.org/article/a697cf71179040959ea3f405db8b74ba
Autor:
Aneta Aleksova, Alessia Paldino, Antonio Paolo Beltrami, Laura Padoan, Massimo Iacoviello, Gianfranco Sinagra, Michele Emdin, Alan S. Maisel
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 2, p 270 (2019)
Soluble ST2 (sST2) has recently emerged as a promising biomarker in the field of acute cardiovascular diseases. Several clinical studies have demonstrated a significant link between sST2 values and patients’ outcome. Further, it has been found that
Externí odkaz:
https://doaj.org/article/720acec7e47b462aae2d87170516c85c